Tuesday Dec 12, 2023

09 – A New Era of GVHD Prevention Post-HCT, Pt. 2: Progressive Research and the Future of Care

In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

In Part II: Progressive Research and the Future of Care, guests dive deeper into the results of their recently published clinical trial outlining a novel drug combination for GVHD prevention, address the importance of ongoing communication, and take a look at how research is continuing to progress to promote a new standard of care.

To read bios on the panelists and to access additional resources related to this episode, visit Our Site

Copyright 2021 All rights reserved.

Version: 20240320